欢迎来到第壹文秘! | 帮助中心 分享价值,成长自我!
第壹文秘
全部分类
  • 幼儿/小学教育>
  • 中学教育>
  • 高等教育>
  • 研究生考试>
  • 外语学习>
  • 资格/认证考试>
  • 论文>
  • IT计算机>
  • 法律/法学>
  • 建筑/环境>
  • 通信/电子>
  • 医学/心理学>
  • ImageVerifierCode 换一换
    首页 第壹文秘 > 资源分类 > PPT文档下载
    分享到微信 分享到微博 分享到QQ空间

    自体免疫疾病.ppt

    • 资源ID:466364       资源大小:6.86MB        全文页数:59页
    • 资源格式: PPT        下载积分:10金币
    快捷下载 游客一键下载
    账号登录下载
    三方登录下载: 微信开放平台登录 QQ登录
    下载资源需要10金币
    邮箱/手机:
    温馨提示:
    快捷下载时,如果您不填写信息,系统将为您自动创建临时账号,适用于临时下载。
    如果您填写信息,用户名和密码都是您填写的【邮箱或者手机号】(系统自动生成),方便查询和重复下载。
    如填写123,账号就是123,密码也是123。
    支付方式: 支付宝    微信支付   
    验证码:   换一换

    加入VIP,免费下载
     
    账号:
    密码:
    验证码:   换一换
      忘记密码?
        
    友情提示
    2、PDF文件下载后,可能会被浏览器默认打开,此种情况可以点击浏览器菜单,保存网页到桌面,就可以正常下载了。
    3、本站不支持迅雷下载,请使用电脑自带的IE浏览器,或者360浏览器、谷歌浏览器下载即可。
    4、本站资源下载后的文档和图纸-无水印,预览文档经过压缩,下载后原文更清晰。
    5、试题试卷类文档,如果标题没有明确说明有答案则都视为没有答案,请知晓。

    自体免疫疾病.ppt

    自体免疫疾病自体免疫疾病器官特异性非器官特异性自体免疫疾病自体免疫疾病肌肉肾脏皮肤关节Pathological Factors in Rheumatic Disorders Rheumatic diseases are multisystem disorders caused by tissue damage resulting from autoantibodies,cytotoxic T lymphocytes,complement-fixing immune complex deposition,and inflammatory mediatorsInflammatory Parameters1.1.ESRESR2.2.Acute phase reactantsAcute phase reactants3.3.ImmunoglobulinsImmunoglobulins4.4.Complement componentsComplement components5.5.Inflammatory mediators:cytokines,Inflammatory mediators:cytokines,prostanoidsprostanoids ESR are determined by the three forces Surface free energy(Van de Waals force):cohesive force Electrical charge associated with RBC:repulsive force Dielectric constant of the medium:dissipates the forceCalculation Equation for ESR Vs=2/9x(Ps-PL)R2/n x gVs=2/9x(Ps-PL)R2/n x gVs=the limiting velocity of the sphereVs=the limiting velocity of the sphereR=the radius of the sphereR=the radius of the spherePs and PL=the densities of the sphere and Ps and PL=the densities of the sphere and of the liquidof the liquidg=the acceleration due to gravityg=the acceleration due to gravityn=the viscosity of the liquidn=the viscosity of the liquidSerum Proteins and Drugs That Affect the ESR RateESR increaseESR decrease Fibrinogen ACTH Immunoglobulins Cortisone Dextran Ethambutol Methyldopa Quinine Procainamide Salicylate Oral contraceptives Penicillamine Methylsergide Theophylline Trifluperidol Vitamine AAcute Phase ReactantsThe Acute Phase Response Follows Cell Injury and The Acute Phase Response Follows Cell Injury and Tissue Damage Caused by:Tissue Damage Caused by:Acute infections:i.e.,bacterial or parasiticAcute infections:i.e.,bacterial or parasiticTrauma:i.e.,blunt,surgery,and burnsTrauma:i.e.,blunt,surgery,and burnsIschemic necrosis:i.e.,acute myocardial Ischemic necrosis:i.e.,acute myocardial infarctioninfarctionMalignant disease:I.e.,tumor growth and Malignant disease:I.e.,tumor growth and metastasismetastasisConnective tissue disease:i.e.,rheumatoid Connective tissue disease:i.e.,rheumatoid arthritis,rheumatic fever and othersarthritis,rheumatic fever and othersAcute abdominal inflammation:i.e.cholecystitis Acute abdominal inflammation:i.e.cholecystitis and pancreatitisand pancreatitisVaccination:I.e.,typhoidVaccination:I.e.,typhoidFunctional Properties of Human Acute Phase ProteinsFunctional GroupProteinFunctionHost defense proteinsC-reactive protein(CRP)Complement activation,opsonicationMannan-binding protein(MBP)Complement activation,opsonizationComplement proteins C3,C4,C5 Factor B,C9 Factor H,C4bpIncreased vascular permeability,opsonization,bacterial killingFibrinogenFormation of hemostatic plugs,wound healingProteinase inhibitors 1-Proteinase inhibitor(1-PI)Control of extracellular matrix degradation 1-Antichymotrypsin(1-Achy)Control of extracellular matrix degradation 2-Antiplasmin(2-AP)Control of plasminC1 inhibitor(C1 INH)Control of complement and contace system activationAntioxidantsCeruloplaasminInhibition of oxy radical formationHemopexin(Hx)Binding of heme,inhibition of lipid peroxidationHaptoglobulin(HP)Binding of hemoglobulin,inhibition of lipid peroxidationFunction unknownSerum amyloid A(SAA)1-Acid glycoproteinC-Reactive Protein(CRP)Normal plasma protein,concentration from Normal plasma protein,concentration from 0.068-8.8 mg/ml0.068-8.8 mg/mlAcute phase reactant,concentration up to Acute phase reactant,concentration up to 500mg/ml500mg/mlSynthesized by hepatocytesSynthesized by hepatocytesMolecular weight 105,500 daltonsMolecular weight 105,500 daltonsFive identical non-glycosylated,non-Five identical non-glycosylated,non-covalently associated subunitscovalently associated subunitsAmino acid sequence homologous with serum Amino acid sequence homologous with serum amyloid A component(SAA)amyloid A component(SAA)Rheumatic Disease in Which Elevated C-Reactive Protein Levels may OccurGoutRheumatoid arthritisJuvenile rheumatoid arthritisPsoriatic arthritisAnkylosing spondylitisReiters syndromePolymyalgia rheumatica-giant cell arteritisSystemic vasculitisWegeners granulomatosisBehcets syndromeSystemic lupus erythematosusc ACRc ACR类风湿性关节炎类风湿性关节炎(RA)(RA)类风湿性关节炎类风湿性关节炎(RA)(RA)1.类风湿性关节炎是一种重要的自体免疫疾病,可导致关节破坏变形,骨骼变化以及全身性的病变。2.类风湿性关节炎的骨骼变化包括发炎关节旁的骨缺乏,软骨侵蚀。3.类风湿性关节炎是一种全身性的变化,患者不但关节疼痛,可能关节会逐渐变形。4.过去十年来,类风湿关节炎在冶疗上的改变有着明显的进步。我们不再视其为一仅局限于关节的慢性病变;反之,却视为一甚富侵略性的全身性疾患。Rheumatoid Arthritis(RA)Rheumatoid Arthritis(RA)A chronic,systemic,autoimmune,A chronic,systemic,autoimmune,inflammatory disease of unknown inflammatory disease of unknown etiologyetiologyCharacterized by Characterized by persistent intense immunological persistent intense immunological activityactivityinflammatory and erosive inflammatory and erosive synovitis,usually involving synovitis,usually involving peripheral joint in a symmetric peripheral joint in a symmetric fashionfashionlocal destruction of bone and local destruction of bone and cartilagecartilagea variety of systemic a variety of systemic manifestation.manifestation.The

    注意事项

    本文(自体免疫疾病.ppt)为本站会员(p**)主动上传,第壹文秘仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对上载内容本身不做任何修改或编辑。 若此文所含内容侵犯了您的版权或隐私,请立即通知第壹文秘(点击联系客服),我们立即给予删除!

    温馨提示:如果因为网速或其他原因下载失败请重新下载,重复下载不扣分。




    关于我们 - 网站声明 - 网站地图 - 资源地图 - 友情链接 - 网站客服 - 联系我们

    copyright@ 2008-2023 1wenmi网站版权所有

    经营许可证编号:宁ICP备2022001189号-1

    本站为文档C2C交易模式,即用户上传的文档直接被用户下载,本站只是中间服务平台,本站所有文档下载所得的收益归上传人(含作者)所有。第壹文秘仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对上载内容本身不做任何修改或编辑。若文档所含内容侵犯了您的版权或隐私,请立即通知第壹文秘网,我们立即给予删除!

    收起
    展开